TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 28443702

Group type: EXPERIMENTAL
Intervention: Turmeric supplementation (6 capsules daily for 12 weeks, each containing 500 mg turmeric powder)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo (6 capsules daily for 12 weeks)
Number of subjects: 46
Study: 27900700

Group type: EXPERIMENTAL
Intervention: PRP supplementation
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: PRP group
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 22892060

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT)
Number of subjects: 378

Group type: COMPARATOR
Intervention: No HRT (Control)
Number of subjects: 378
Study: 21349929

Group type: EXPERIMENTAL
Intervention: UFH tid
Number of subjects: 27667

Group type: COMPARATOR
Intervention: LMWH
Number of subjects: 27667

Group type: COMPARATOR
Intervention: UFH bid
Number of subjects: 27667
Study: 19615860

Group type: EXPERIMENTAL
Intervention: Sodium Nitroprusside (SNP)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Nitroglycerin (NTG)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Sevoflurane (SEV)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: All groups (SNP, NTG, SEV)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: SNP vs NTG
Number of subjects: 36

Group type: COMPARATOR
Intervention: SNP vs SEV
Number of subjects: 36

Group type: COMPARATOR
Intervention: NTG vs SEV
Number of subjects: 36
Study: 17908543

Group type: EXPERIMENTAL
Intervention: Helioseal Clear Chroma
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Teethmate F1
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Tetric Flow
Number of subjects: 41
Study: 14745744

Group type: EXPERIMENTAL
Intervention: Psychoeducational group intervention
Number of subjects: 60

Group type: COMPARATOR
Intervention: No-treatment control group
Number of subjects: 60
Study: 11217590

Group type: EXPERIMENTAL
Intervention: Articaine (4 percent with epinephrine 1:100,000)
Number of subjects: 1325

Group type: COMPARATOR
Intervention: Lidocaine (2 percent with epinephrine 1:100,000)
Number of subjects: 1325
Study: 9764991

Group type: EXPERIMENTAL
Intervention: 500 mg/day for 2 weeks (Group 1)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: 1000 mg twice a week for 2 weeks (Group 2)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: 1000 mg once a week for 2 weeks (Group 3)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: 1000 mg once a week for 12 weeks (Group 4)
Number of subjects: 29
Study: 8550361

Group type: EXPERIMENTAL
Intervention: Subcutaneous sumatriptan 6 mg
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Subcutaneous sumatriptan 6 mg (second injection)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Subcutaneous sumatriptan 6 mg (rescue medication)
Number of subjects: 80
Study: 2204432

Group type: EXPERIMENTAL
Intervention: Yohimbine (20 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 719892

Group type: EXPERIMENTAL
Intervention: 100 mg vitamin E daily for two weeks
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 45
Study: 31833004

Group type: EXPERIMENTAL
Intervention: Low-level laser irradiation (LLLI)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Pseudo-laser treatment
Number of subjects: 27
Study: 31812472

Group type: EXPERIMENTAL
Intervention: Fundus autofluorescence imaging (FAF)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Electroretinography (ERG) group 3 phenotype
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: DAF area quantification
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: DAF area
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Longitudinal FAF imaging
Number of subjects: 90
Study: 28289815

Group type: EXPERIMENTAL
Intervention: Short-axis ultrasound-guided cannulation
Number of subjects: 190

Group type: COMPARATOR
Intervention: Long-axis ultrasound-guided cannulation
Number of subjects: 190
Study: 25185212

Group type: EXPERIMENTAL
Intervention: 10-25 Hz PPNa stimulation
Number of subjects: 9

Group type: COMPARATOR
Intervention: 60-80 Hz PPNa stimulation
Number of subjects: 9
Study: 23514253

Group type: EXPERIMENTAL
Intervention: Middle-age recurrent patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Older recurrent patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Older nonrecurrent patients
Number of subjects: 0
Study: 21812357

Group type: EXPERIMENTAL
Intervention: Magnesium carbonate 3 x 1 g
Number of subjects: 64

Group type: COMPARATOR
Intervention: Sevelamer hydrochloride 0.8 g‐‐3 x 2 tabl (3 x 1.6 g)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Calcium carbonate 3 x 2 g
Number of subjects: 64
Study: 19376184

Group type: EXPERIMENTAL
Intervention: Catecholamine depletion using alpha‐methyl‐para‐tyrosine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo procedure
Number of subjects: 0
Study: 16434589

Group type: EXPERIMENTAL
Intervention: Genetic counseling intervention arm
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Overall cohort
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Women without cancer at enrollment
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Women found to be BRCA1/2 carriers
Number of subjects: 243
Study: 15530754

Group type: EXPERIMENTAL
Intervention: Counseling
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Counseling + fitness testing
Number of subjects: 155

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 155
Study: 10965439

Group type: EXPERIMENTAL
Intervention: Trimovax vaccine
Number of subjects: 372
Study: 9244021

Group type: EXPERIMENTAL
Intervention: First arterial sample (discard volume 4.5 ml)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Second arterial sample (discard volume 16 ml)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Venous samples
Number of subjects: 79
Study: 7961017

Group type: EXPERIMENTAL
Intervention: Accelerated hyperfractionation (AHF)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Conventional fractionation (1.7‐2.0 Gy/day, five times/week)
Number of subjects: 88

Group type: COMPARATOR
Intervention: External RT alone
Number of subjects: 88
Study: 3661368

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Phenylephrine (PE)
Number of subjects: 19
Study: 29019860

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma
Number of subjects: 32

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 32
Study: 27039753

Group type: EXPERIMENTAL
Intervention: School-based smoke-free home program (SFH) implemented in classroom and home over 1 month
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group with no intervention
Number of subjects: 12
Study: 22575796

Group type: EXPERIMENTAL
Intervention: Group-mediated cognitive behavioral (GMCB) exercise intervention
Number of subjects: 80

Group type: COMPARATOR
Intervention: Traditional center-based exercise therapy approach (TRAD)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: GMCB and TRAD interventions
Number of subjects: 80
Study: 20841623

Group type: EXPERIMENTAL
Intervention: Knee extension training (unilateral knee extension at 80% of 1 repetition maximum, 10 repetitions per set, 4 days/week for 12 weeks)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Plantar flexion training (unilateral plantar flexion at 80% of 1 repetition maximum, 10 repetitions per set, 4 days/week for 12 weeks)
Number of subjects: 20
Study: 18952312

Group type: COMPARATOR
Intervention: Exercise only (G2)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Diet plus exercise (G3)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Diet only (G4)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (G1)
Number of subjects: 45
Study: 16193898

Group type: EXPERIMENTAL
Intervention: Autoinjector
Number of subjects: 1825

Group type: COMPARATOR
Intervention: Manual injection
Number of subjects: 1825
Study: 13678478

Group type: EXPERIMENTAL
Intervention: Clarithromycin extended-release (ER) 500 mg once daily for 5 days
Number of subjects: 351

Group type: COMPARATOR
Intervention: Clarithromycin immediate-release (IR) 250 mg twice daily for 5 days
Number of subjects: 351
Study: 10873979

Group type: EXPERIMENTAL
Intervention: Latanoprost
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Timolol
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Brimonidine
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Betaxolol
Number of subjects: 141

Group type: COMPARATOR
Intervention: Overall management
Number of subjects: 141
Study: 8860765

Group type: EXPERIMENTAL
Intervention: Unilateral submandibular gland resection
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Bilateral submandibular gland resection
Number of subjects: 66

Group type: COMPARATOR
Intervention: Noncancer control subjects
Number of subjects: 66
Study: 1735395

Group type: EXPERIMENTAL
Intervention: Tramadol 15 mg h‐1 infusion (Group I)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Saline (Group II)
Number of subjects: 35
Study: 6336600

Group type: EXPERIMENTAL
Intervention: Spironolactone, 400 mg/d
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Chlorthalidone, 100 mg/d
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 30723231

Group type: EXPERIMENTAL
Intervention: Placebos provided with a psychological treatment rationale
Number of subjects: 0
Study: 29467885

Group type: EXPERIMENTAL
Intervention: Nedaplatin (NDP) plus paclitaxel
Number of subjects: 182

Group type: COMPARATOR
Intervention: Carboplatin (CBP) plus paclitaxel
Number of subjects: 182
Study: 27843307

Group type: EXPERIMENTAL
Intervention: Conjugated linoleic acid (CLA) supplementation, 3.2 g daily for 6 weeks
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study: 24621319

Group type: EXPERIMENTAL
Intervention: Zonisamide (1 mg/kg/day up-titrated to 8 mg/kg/day, maximum 500 mg/day)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Zonisamide
Number of subjects: 144
Study: 23194138

Group type: EXPERIMENTAL
Intervention: Skills-based child sexual abuse prevention program (immediate training)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Waiting-list control condition (delayed training)
Number of subjects: 46
Study: 19664156

Group type: EXPERIMENTAL
Intervention: Google search for diagnosis by Investigator A (Consultant with expert knowledge in IM&A)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Google search for diagnosis by Investigator B (Registrar in IM&A)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Google search for diagnosis by Investigator C (Research Nurse)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: All investigators combined
Number of subjects: 45
Study: 17501980

Group type: EXPERIMENTAL
Intervention: Nobel Direct and Nobel Perfect one-piece implants (OPIs)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Two-piece implants (TPIs)
Number of subjects: 48
Study: 15163440

Group type: EXPERIMENTAL
Intervention: Zolpidem 10 mg
Number of subjects: 163

Group type: COMPARATOR
Intervention: Temazepam 20 mg
Number of subjects: 163
Study: 11477354

Group type: EXPERIMENTAL
Intervention: Hand-assisted laparoscopic live donor nephrectomy
Number of subjects: 70

Group type: COMPARATOR
Intervention: Open surgical live donor nephrectomy
Number of subjects: 70
Study: 10091071

Group type: EXPERIMENTAL
Intervention: EllioStep2
Number of subjects: 416
Study: 7835856

Group type: EXPERIMENTAL
Intervention: Capitated payment system (CPS) for continuous patients (N = 201)
Number of subjects: 356

Group type: EXPERIMENTAL
Intervention: Partial capitation condition for intermittent patients (N = 155)
Number of subjects: 356

Group type: COMPARATOR
Intervention: Control group (traditional fee-for-service care)
Number of subjects: 356
Study: 17171884

Group type: EXPERIMENTAL
Intervention: Sufentanil
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Fentanyl
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 50
Study: 29581202

Group type: EXPERIMENTAL
Intervention: Non-interventional methods for assessing COPD treatment effectiveness
Number of subjects: 3000000

Group type: COMPARATOR
Intervention: Individual trial data from the TORCH trial
Number of subjects: 3000000
Study: 26562679

Group type: EXPERIMENTAL
Intervention: Combination of motivational enhancement and cognitive behavioral therapy
Number of subjects: 74

Group type: COMPARATOR
Intervention: Combination treatment plus additional 'check-up' sessions
Number of subjects: 74
Study: 24660157

Group type: EXPERIMENTAL
Intervention: Glide Scope video laryngoscope
Number of subjects: 300

Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 300
Study: 23377590

Group type: EXPERIMENTAL
Intervention: Progressive resistance training (PRT) for 30 minutes per session, 3 sessions a week, for 12 weeks.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Usual care (comparison group).
Number of subjects: 40
Study: 19896633

Group type: EXPERIMENTAL
Intervention: Dispersive OVD (Viscoat)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Cohesive OVD (Healon GV)
Number of subjects: 60
Study: 18178097

Group type: EXPERIMENTAL
Intervention: Novel agents (thalidomide, lenalidomide, bortezomib, dexamethasone)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Baseline serum levels of angiogenic cytokines
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: BM MVD
Number of subjects: 44
Study: 15890755

Group type: EXPERIMENTAL
Intervention: HbSS RBCs
Number of subjects: 30

Group type: COMPARATOR
Intervention: HbAS RBCs
Number of subjects: 30

Group type: COMPARATOR
Intervention: HbAA RBCs
Number of subjects: 30
Study: 14636114

Group type: EXPERIMENTAL
Intervention: Physioball core stability and balance exercises
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional floor exercises
Number of subjects: 30
Study: 11116534

Group type: EXPERIMENTAL
Intervention: W. somnifera root powder for 30 days
Number of subjects: 12
Study: 8790203

Group type: EXPERIMENTAL
Intervention: Rhenium-186-etidronate (doses ranging from 1295 MBq to 3515 MBq)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 43
Study: 1346951

Group type: EXPERIMENTAL
Intervention: Vitamin E
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 6734920

Group type: EXPERIMENTAL
Intervention: Dicyclomine (Merbentyl)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Dicyclomine (Merbentyl) + Antacid
Number of subjects: 42

Group type: COMPARATOR
Intervention: Dicyclomine (Merbentyl) + Placebo
Number of subjects: 42
Study: 31557520

Group type: EXPERIMENTAL
Intervention: CVVHDF
Number of subjects: 41

Group type: COMPARATOR
Intervention: Standard of care (control)
Number of subjects: 41
Study: 29444771

Group type: EXPERIMENTAL
Intervention: Ultra-processed food intake
Number of subjects: 104980
Study: 27252426

Group type: EXPERIMENTAL
Intervention: ETN 25 mg plus MTX
Number of subjects: 306

Group type: COMPARATOR
Intervention: MTX alone
Number of subjects: 306

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: ETN reduced-dose group
Number of subjects: 306
Study: 24803381

Group type: EXPERIMENTAL
Intervention: Incentive (INC)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control (CTL)
Number of subjects: 120
Study: 21279478

Group type: EXPERIMENTAL
Intervention: Mesalamine 800 mg b.i.d for 10 days every month
Number of subjects: 149

Group type: COMPARATOR
Intervention: No 5-ASA medications
Number of subjects: 149
Study: 20709109

Group type: COMPARATOR
Intervention: Hydroxyethyl cellulose (HEC) gel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Methylcellulose (MC) gel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Thin gel layers in Transwell system
Number of subjects: 0
Study: 18004139

Group type: EXPERIMENTAL
Intervention: levodopa (100 mg)
Number of subjects: 13

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 13
Study: 15882720

Group type: EXPERIMENTAL
Intervention: Collagen injection
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 133
Study: 12640085

Group type: EXPERIMENTAL
Intervention: Patients with trigeminal neuralgia, right carotid artery AIx
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Patients with trigeminal neuralgia, left carotid artery AIx
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group, right carotid artery AIx
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group, left carotid artery AIx
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Patients with trigeminal neuralgia, ascending aorta AIx
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group, ascending aorta AIx
Number of subjects: 32

Group type: COMPARATOR
Intervention: Comparison of right carotid artery AIx
Number of subjects: 32

Group type: COMPARATOR
Intervention: Comparison of left carotid artery AIx
Number of subjects: 32

Group type: COMPARATOR
Intervention: Comparison of ascending aorta AIx
Number of subjects: 32
Study: 11203756

Group type: EXPERIMENTAL
Intervention: Capsaicin injection after tooth grinding (exercise session)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Capsaicin injection without tooth grinding (non-exercise session)
Number of subjects: 10
Study: 8866629

Group type: EXPERIMENTAL
Intervention: Pravastatin (20 mg) administered in the morning
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Pravastatin (20 mg) administered in the evening
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Pravastatin (20 mg) administered in the morning or evening
Number of subjects: 11
Study: 1506394

Group type: EXPERIMENTAL
Intervention: Nitroprusside infusion
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Phenylephrine infusion
Number of subjects: 9
Study: 6143185

Group type: EXPERIMENTAL
Intervention: Imipenem plus cilastatin (I/C group)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Gentamicin and clindamycin (G/C group)
Number of subjects: 163
Study: 31924355

Group type: EXPERIMENTAL
Intervention: Robotic sleeve lobectomy
Number of subjects: 188

Group type: COMPARATOR
Intervention: Video-assisted thoracoscopic surgery (VATS)
Number of subjects: 188

Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 188
Study: 29866601

Group type: EXPERIMENTAL
Intervention: ICT/CCRT
Number of subjects: 151

Group type: COMPARATOR
Intervention: CCRT
Number of subjects: 151
Study: 28169885

Group type: EXPERIMENTAL
Intervention: Repeated sleep restriction (4 h of sleep/night from 0300 to 0700 h for three nights followed by recovery sleep of 8 h, repeated four times in succession)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Sleep control group (8 h/night from 2300 to 0700 h)
Number of subjects: 45
Study: 26666457

Group type: EXPERIMENTAL
Intervention: Sensorimotor training (SMT) with 15 minutes added to standard physiotherapy (PT) treatment
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard physiotherapy (PT) treatment with 15 minutes of sub-effective low-intensity endurance training
Number of subjects: 20

Group type: COMPARATOR
Intervention: Healthy control group (n=20) for cross-sectional comparison
Number of subjects: 20
Study: 23544761

Group type: EXPERIMENTAL
Intervention: Adherent lifestyle participants
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adherent metformin participants
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo participants
Number of subjects: 0
Study: 21140360

Group type: EXPERIMENTAL
Intervention: Sutureless StatLock attachment device
Number of subjects: 72

Group type: COMPARATOR
Intervention: Traditional suture fixation
Number of subjects: 72
Study: 17578859

Group type: EXPERIMENTAL
Intervention: Vitamin D levels measured every 3 months and at relapse
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Intact parathyroid hormone (iPTH) levels measured every 3 months and at relapse
Number of subjects: 23

Group type: COMPARATOR
Intervention: MRI burden of disease and T2 activity assessed every 6 months
Number of subjects: 23

Group type: COMPARATOR
Intervention: Seasonal variation of 25(OH)D
Number of subjects: 23

Group type: COMPARATOR
Intervention: Vitamin D deficiency defined as S-25(OH)D < or = 37 nmol/l
Number of subjects: 23

Group type: COMPARATOR
Intervention: Calcium, phosphate, magnesium, chloride, alkaline phosphatase, albumin, and thyroid stimulating hormone levels measured
Number of subjects: 23
Study: 16413145

Group type: EXPERIMENTAL
Intervention: Couple-based interventions to facilitate risk communication and promote condom use among male IDUs
Number of subjects: 22
Study: 12734710

Group type: EXPERIMENTAL
Intervention: Kennedy ligament augmentation device (LAD)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional medial patellar tendon strip procedure
Number of subjects: 40
Study: 10706012

Group type: EXPERIMENTAL
Intervention: Turkish patients (Tr-Pat)
Number of subjects: 150

Group type: COMPARATOR
Intervention: German patients (G-Pat)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Turkish patients (Tr-Pat) with 'bad' German knowledge
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Turkish patients (Tr-Pat) with 'good' German knowledge
Number of subjects: 150
Study: 9366820

Group type: EXPERIMENTAL
Intervention: Oral terbinafine 250 mg/day for 12 or 24 weeks
Number of subjects: 358
Study: 1383825

Group type: EXPERIMENTAL
Intervention: Buprenorphine (8 mg SL daily)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Buprenorphine (8 mg SL every other day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Buprenorphine
Number of subjects: 0
Study: 6427848

Group type: EXPERIMENTAL
Intervention: Lithicarb (standard lithium carbonate preparation)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Priadel (sustained-release lithium carbonate preparation)
Number of subjects: 14
Study: 30875527

Group type: EXPERIMENTAL
Intervention: ADSTEP (Assistive Device Selection, Training and Education Program) - a multicomponent program of walking aid selection, fitting and six weekly progressive task‐oriented walking aid training sessions
Number of subjects: 14
Study: 30312957

Group type: EXPERIMENTAL
Intervention: Zero-time exercise (ZTEx)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Sleep hygiene education (SHE)
Number of subjects: 37